Hematologic Malignancy (Leukemia/Lymphoma)
The Hematologic Malignancy Program consists of a multidisciplinary team focused on the prevention, diagnosis, and treatment of pediatric and adolescent cancers arising in the bone marrow, lymph nodes and other associated organs. The program is also focused on the education of students, residents and fellows who will be conducting scholarly and peer-reviewed clinical, translational and basic research in hematologic malignancies.
The Hematological Malignancy Program has several of the most relevant basic, translational and clinical research programs in Acute Leukemias, Non-Hodgkin Lymphoma, Hodgkin Lymphoma and other associated hematologic malignancies. Overall the program is equipped to design and deliver customized and personalized therapy for each child and adolescent in the cancer center diagnosed with a hematologic malignancy.
Diseases We Treat
An asterisk indicates our practice is involved in a clinical trial associated with the disease. View our current clinical trials here.
Unique Features
- Customized patient treatment protocols
- Ten protective isolation hospital rooms for induction therapy and stem cell transplantation
-
Outpatient Infusion Center for patient specific therapies
- Advanced Diagnostic Laboratories
-
Local and total body radiation facilities
- Targeted and developmental Therapeutics
- Monoclonal antibody and radio-conjugate antibody therapies
- Comprehensive Stem and Cellular Therapy and Transplantation Program
- Cellular and Tissue Engineering Laboratory
- Multidisciplinary team
Research and Education Highlights
-
ACGME Accredited Pediatric Hematology, Oncology and Stem Cell Transplantation Fellowship Training Program
- Student, resident and other allied health professional elective/selectives
- Children’s Oncology Group (COG) Member Institution
- Childhood, Adolescent and Young Adult Lymphoma Cell Therapy Consortium (LCTC), Lead Institution
- Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma Translational Research and Treatment Consortium, Lead Institute
- Stem Cell Transplantation for Poor Risk Acute Leukemia Consortium, Lead Institution
- Pediatric Transplant and Cell Therapy Consortium (PTCTC), Member Institution
- National Marrow Donor Program (NMDP), Member Institution
- Leukemia and Lymphoma Cancer Genetics Research Program
-
Leukemia and Lymphoma Tumor Immunology and Cellular Therapeutics Research Program
Contact Us
Pediatric Hematology, Oncology and Stem Cell Transplant
Maria Fareri Children’s Hospital
100 Woods Road
Valhalla, NY 10595
914.614.4270
Jessica Hochberg, MD
Jessica.Hochberg@wmchealth.org
914.614.4270
Jackie Basso, RN, MSN, CPNP
Jaclyn.Basso@wmchealth.org
914.614.4270
By Car
Train
Maria Fareri Children’s Hospital is served by Metro North's Harlem line via two stations:
- White Plains - Bus transfer options available
- Hawthorne - Taxi service available
For train fare and schedule information, call 1-800-METRO-INFO or go to METRO NORTH
Bus
There are three bus lines (Westchester Bee Line) you can take to our campus. Please call 914.813.7777 for bus routes and fares.
Campus Map
The Westchester Medical Center campus includes the Maria Fareri Children's Hospital and the Behavioral Health Center.
Mitchell Cairo, MD
Chief, Pediatric Hematology, Oncology and Stem Cell Transplantation;
Director, Childhood and Adolescent Cancer and Blood Diseases Center
- Pediatrics, Pediatric Hematology-Oncology
- Pathology, Anatomic Pathology & Clinical Pathology
Allyson Flower, MD
Assistant Professor of Pediatrics and Microbiology, Immunology,
Clinical Director, Pediatric Stem Cell and Cell Transplant Program
- Pediatrics, Pediatric Hematology-Oncology
- Pediatrics, Pediatric Hematology-Oncology
Edward Halperin, MD
Chancellor, Chief Executive Officer New York Medical College,
Department of Radiation Medicine
- Pediatrics, Pediatric Hematology-Oncology
Nurse Coordinator:
Jackie Basso, RN, MSN, CPNP
Jaclyn.Basso@wmchealth.org
914.614.4270
,